|
Re: Question about publications - Nature
|
1
|
Resverlogix Corp.
|
Feb 11, 2022 01:23PM
|
|
Re: Question about publications - Nature
|
1
|
Resverlogix Corp.
|
Feb 11, 2022 01:35PM
|
|
Re: Option #2 and Option #3 questions
|
1
|
Resverlogix Corp.
|
Oct 27, 2020 02:16PM
|
|
Re: Tweet from Prof Kausik Ray
|
1
|
Resverlogix Corp.
|
Jun 01, 2020 01:24PM
|
|
Re: Question about publications - Nature
|
1
|
Resverlogix Corp.
|
Feb 11, 2022 03:10PM
|
|
BIO - Europe Digital - 2020
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 21, 2020 02:41PM
|
|
Eastern Capital - Expiration of warrants
|
2
|
Resverlogix Corp.
|
Jul 23, 2020 06:11PM
|
|
Re: New Presentation
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 23, 2020 07:03PM
|
|
RVX Provides Update Regarding Extension if its Filing Calendar
|
2
|
Resverlogix Corp.
|
Aug 28, 2020 07:11PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
May 26, 2020 06:13PM
|
|
Blood Brain Barrier Summit
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 29, 2020 11:55AM
|
|
Re: Proactive Article - new presentation on website
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 19, 2020 09:39AM
|
|
Aposense
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2021 06:06PM
|
|
Re: Would a functional cure for T1D affect RVX and T2D?
|
2
|
Resverlogix Corp.
|
Jan 17, 2021 05:10PM
|
|
75,000 options expired
|
2
|
Resverlogix Corp.
|
Aug 11, 2020 06:05PM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
2
|
Resverlogix Corp.
|
Jan 13, 2021 04:58PM
|
|
New Preprint Published Today - ACE2 inhibitors produce improved outcomes - SARS-CoV-2
|
2
|
Resverlogix Corp.
|
Apr 04, 2020 09:58AM
|
|
Re: For those who missed it live...
|
2
|
Resverlogix Corp.
|
May 13, 2021 10:51AM
|
|
Q1 financials posted
|
2
|
Resverlogix Corp.
|
May 17, 2021 10:34PM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
2
|
Resverlogix Corp.
|
Jan 18, 2021 07:51AM
|
